Vanguard reports 0 shares of Plexus Corp common stock
The Vanguard Group amended its Schedule 13G/A to report 03/13/2026 as the relevant date and zero shares of Plexus Corp common stock beneficially owned.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
The Vanguard Group amended its Schedule 13G/A to report 03/13/2026 as the relevant date and zero shares of Plexus Corp common stock beneficially owned. The filing (Amendment No. 18) states 0 shares and 0% ownership and includes a disclosure that Vanguard completed an internal realignment on January 12, 2026, after which certain subsidiaries will report holdings separately.
Insights
Vanguard's amendment reports no beneficial ownership and cites organizational realignment.
The filing records 0 shares and 0% of Plexus Corp as of 03/13/2026. It attributes separate reporting to an internal realignment completed on January 12, 2026, consistent with SEC guidance allowing disaggregation.
Cash‑flow treatment is not stated. Subsequent Schedule filings from Vanguard affiliates may show positions; monitor future ownership disclosures for any reaggregation or affiliate holdings.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Vanguard's Schedule 13G/A amendment for PLXS report?
How should investors interpret Vanguard's 0% stake in PLXS?
Where is the amendment signed and who filed it for PLXS?
AI-generated analysis. How Rhea-AI works. Not financial advice.